| Literature DB >> 29506669 |
Manuel Valiente1, Manmeet S Ahluwalia2, Adrienne Boire3, Priscilla K Brastianos4, Sarah B Goldberg5, Eudocia Q Lee6, Emilie Le Rhun7, Matthias Preusser8, Frank Winkler9, Riccardo Soffietti10.
Abstract
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Entities:
Keywords: brain metastasis; genomics; microenvironment; neurocognition; prevention; therapy
Mesh:
Substances:
Year: 2018 PMID: 29506669 PMCID: PMC6602095 DOI: 10.1016/j.trecan.2018.01.003
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025